The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers (Englisch)
- Neue Suche nach: Garg, V.
- Neue Suche nach: Chandorkar, G.
- Neue Suche nach: Yang, Y.
- Neue Suche nach: Adda, N.
- Neue Suche nach: McNair, L.
- Neue Suche nach: Alves, K.
- Neue Suche nach: Smith, F.
- Neue Suche nach: Heeswijk, R. P.
- Neue Suche nach: Garg, V.
- Neue Suche nach: Chandorkar, G.
- Neue Suche nach: Yang, Y.
- Neue Suche nach: Adda, N.
- Neue Suche nach: McNair, L.
- Neue Suche nach: Alves, K.
- Neue Suche nach: Smith, F.
- Neue Suche nach: Heeswijk, R. P.
In:
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
;
75
, 2
;
431-439
;
2013
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers
-
Beteiligte:Garg, V. ( Autor:in ) / Chandorkar, G. ( Autor:in ) / Yang, Y. ( Autor:in ) / Adda, N. ( Autor:in ) / McNair, L. ( Autor:in ) / Alves, K. ( Autor:in ) / Smith, F. ( Autor:in ) / Heeswijk, R. P. ( Autor:in )
-
Erschienen in:BRITISH JOURNAL OF CLINICAL PHARMACOLOGY ; 75, 2 ; 431-439
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2013
-
Format / Umfang:9 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 615.1
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 615.1 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 75, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 301
-
Editors’ Report, 2012Loke, Yoon K. / Cohen, Adam F. / Ferro, Albert / Lewis, Lionel D. / Ritter, James M. / Somogyi, Andrew A. et al. | 2013
- 303
-
Cannabidiol as potential anticancer drugMassi, Paola / Solinas, Marta / Cinquina, Valentina / Parolaro, Daniela et al. | 2013
- 313
-
Is the cardiovascular system a therapeutic target for cannabidiol?Stanley, Christopher P. / Hind, William H. / O'Sullivan, Saoirse E. et al. | 2013
- 323
-
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?Fernández‐Ruiz, Javier / Sagredo, Onintza / Pazos, M. Ruth / García, Concepción / Pertwee, Roger / Mechoulam, Raphael / Martínez‐Orgado, José et al. | 2013
- 334
-
Pharmacogenomics of warfarin in populations of African descentSuarez‐Kurtz, Guilherme / Botton, Mariana R. et al. | 2013
- 347
-
Drug‐induced QT interval prolongation: does ethnicity of the thorough QT study population matter?Shah, Rashmi R. et al. | 2013
- 359
-
A systematic review of educational interventions to change behaviour of prescribers in hospital settings, with a particular emphasis on new prescribersBrennan, Nicola / Mattick, Karen et al. | 2013
- 373
-
Online learning applied to a course on rational therapeutics: an international comparison between final year students of two medical schoolsLikic, Robert / White, Casey / Cinti, Sandro / Purkiss, Joel / Fantone, Joseph / Chapman, Chris / Bielen, Luka / Francetic, Igor / Engleberg, Cary et al. | 2013
- 381
-
Double‐blind, randomized, placebo‐controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK‐683, an investigational metastin analogue in healthy menScott, Graham / Ahmad, Irfan / Howard, Katy / MacLean, David / Oliva, Cristina / Warrington, Steve / Wilbraham, Darren / Worthington, Paul et al. | 2013
- 392
-
Insulin at normal physiological levels does not prolong QTc interval in thorough QT studies performed in healthy volunteersTaubel, Jorg / Lorch, Ulrike / Ferber, Georg / Singh, Jatinder / Batchvarov, Velislav N. / Savelieva, Irina / Camm, A. John et al. | 2013
- 404
-
An oral TRPV1 antagonist attenuates laser radiant‐heat‐evoked potentials and pain ratings from UVB‐inflamed and normal skinSchaffler, Klaus / Reeh, Peter / Duan, W. Rachel / Best, Andrea E. / Othman, Ahmed A. / Faltynek, Connie R. / Locke, Charles / Nothaft, Wolfram et al. | 2013
- 415
-
Relationship between the receptor occupancy profile and pleiotropic effects of angiotensin II receptor blockersAndo, Hitoshi / Ushijima, Kentarou / Hosohata, Keiko / Saito, Tetsuo / Fujimura, Akio et al. | 2013
- 423
-
Low doses of fludrocortisone and hydrocortisone, alone or in combination, on vascular responsiveness to phenylephrine in healthy volunteersLaviolle, Bruno / Donal, Erwan / Le Maguet, Pascale / Lainé, Fabrice / Bellissant, Eric et al. | 2013
- 431
-
The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteersGarg, Varun / Chandorkar, Gurudatt / Yang, Yijun / Adda, Nathalie / McNair, Lindsay / Alves, Katia / Smith, Frances / van Heeswijk, Rolf P. G. et al. | 2013
- 440
-
The pharmacokinetics of darexaban are not affected to a clinically relevant degree by rifampicin, a strong inducer of P‐glycoprotein and CYP3A4Groenendaal, Dorien / Strabach, Gregory / Garcia‐Hernandez, Alberto / Kadokura, Takeshi / Heeringa, Marten / Mol, Roelof / Eltink, Charlotte / Onkels, Hartmut et al. | 2013
- 450
-
Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteersVolak, Laurie P. / Hanley, Michael J. / Masse, Gina / Hazarika, Suwagmani / Harmatz, Jerold S. / Badmaev, Vladimir / Majeed, Muhammed / Greenblatt, David J. / Court, Michael H. et al. | 2013
- 463
-
Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factorsFrymoyer, Adam / Verotta, Davide / Jacobson, Pamala / Long‐Boyle, Janel et al. | 2013
- 476
-
Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjectsFrost, Charles / Wang, Jessie / Nepal, Sunil / Schuster, Alan / Barrett, Yu Chen / Mosqueda‐Garcia, Rogelio / Reeves, Richard A. / LaCreta, Frank et al. | 2013
- 488
-
Assessment of potential drug interactions by characterization of human drug metabolism pathways using non‐invasive bile samplingBloomer, Jackie C. / Nash, Mike / Webb, Alison / Miller, Bruce E. / Lazaar, Aili L. / Beaumont, Claire / Guiney, William J. et al. | 2013
- 497
-
Effect of peginterferon alfa‐2a (40KD) on cytochrome P450 isoenzyme activityBrennan, Barbara J. / Xu, Zhi‐Xin / Grippo, Joseph F. et al. | 2013
- 507
-
Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicinDevriese, Lot A. / Witteveen, Petronella (Els) O. / Wanders, Jantien / Law, Kenneth / Edwards, Geoff / Reyderman, Larisa / Copalu, William / Peng, Fuping / Marchetti, Serena / Beijnen, Jos H. et al. | 2013
- 522
-
Association between eIF3α polymorphism and severe toxicity caused by platinum‐based chemotherapy in non‐small cell lung cancer patientsXu, Xiaojing / Han, Lifang / Duan, Li / Zhao, Yingchun / Yang, Huaping / Zhou, Boting / Ma, Rui / Yuan, Ruixia / Zhou, Honghao / Liu, Zhaoqian et al. | 2013
- 535
-
First‐in‐man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarialsMoehrle, Joerg J. / Duparc, Stephan / Siethoff, Christoph / van Giersbergen, Paul L. M. / Craft, J. Carl / Arbe‐Barnes, Sarah / Charman, Susan A. / Gutierrez, Maria / Wittlin, Sergio / Vennerstrom, Jonathan L. et al. | 2013
- 549
-
Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizersLoghin, Corina / Haber, Harry / Beasley, Charles M. Jr / Kothare, Prajakti A. / Kauffman, Lynnette / April, John / Jin, Ling / Allen, Albert J. / Mitchell, Malcolm I. et al. | 2013
- 565
-
Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndromeCoutsouvelis, John / Wiseman, Meredith / Hui, Lisa / Poole, Susan / Dooley, Michael / Patil, Sushrut / Avery, Sharon / Wei, Andrew / Spencer, Andrew et al. | 2013
- 569
-
Rifampicin and dabigatran etexilate: a place for laboratory coagulation monitoringChin, Paul K. L. / Barclay, Murray L. / Begg, Evan J. et al. | 2013
- 571
-
Response to the letter by Dr Chin and co‐workersHärtter, Sebastian / Koenen‐Bergmann, Michael / Sharma, Ashish / Nehmiz, Gerhard / Lemke, Ute / Timmer, Wolfgang / Reilly, Paul A. et al. | 2013
- 572
-
Renal cell carcinoma. Translational biology, personalized medicine and novel therapeutic targetsEditor(s) by Robert A. Figlin, W. Kimryn Rathmell & Brian I. Rini. Published by Springer, New York, USA, 2012. 327 pp, price $189.00, ISBN: 978‐1‐4614‐2399‐7Vasudev, Naveen S. / Larkin, James M. G. et al. | 2013
- 573
-
FASTtrack: Pharmacology, 2nd edn by Michael D. Randall, David A. Kendall, Stephen PH Alexander. Published by Pharmacology Press, London, 2012. 288 pp, paperback price £22.99, ISBN: 978 0 85711 057 2Page, Clive et al. | 2013
- 574
-
Translation Section| 2013
- 574
-
Abstracts of the Dutch Society of Clinical Pharmacology and Biopharmacy Meeting of October 3, 2011| 2013
- i
-
British Journal of Clinical Pharmacology| 2013